TG468: a text graph convolutional network for predicting clinical response to immune checkpoint inhibitor therapy
文献类型:期刊论文
作者 | Wang, Kun3; Shi, Jiangshan2; Tong, Xiaochu2; Qu, Ning2; Kong, Xiangtai2; Ni, Shengkun2; Xing, Jing1; Li, Xutong2; Zheng, Mingyue3![]() |
刊名 | BRIEFINGS IN BIOINFORMATICS
![]() |
出版日期 | 2024-01-22 |
卷号 | 25期号:2页码:15 |
关键词 | immunotherapy clinical response graph convolutional network biomarker |
ISSN号 | 1467-5463 |
DOI | 10.1093/bib/bbae017 |
通讯作者 | Li, Xutong(lixutong@simm.ac.cn) ; Zheng, Mingyue(myzheng@simm.ac.cn) |
英文摘要 | Enhancing cancer treatment efficacy remains a significant challenge in human health. Immunotherapy has witnessed considerable success in recent years as a treatment for tumors. However, due to the heterogeneity of diseases, only a fraction of patients exhibit a positive response to immune checkpoint inhibitor (ICI) therapy. Various single-gene-based biomarkers and tumor mutational burden (TMB) have been proposed for predicting clinical responses to ICI; however, their predictive ability is limited. We propose the utilization of the Text Graph Convolutional Network (GCN) method to comprehensively assess the impact of multiple genes, aiming to improve the predictive capability for ICI response. We developed TG468, a Text GCN model framing drug response prediction as a text classification task. By combining natural language processing (NLP) and graph neural network techniques, TG468 effectively handles sparse and high-dimensional exome sequencing data. As a result, TG468 can distinguish survival time for patients who received ICI therapy and outperforms single gene biomarkers, TMB and some classical machine learning models. Additionally, TG468's prediction results facilitate the identification of immune status differences among specific patient types in the Cancer Genome Atlas dataset, providing a rationale for the model's predictions. Our approach represents a pioneering use of a GCN model to analyze exome data in patients undergoing ICI therapy and offers inspiration for future research using NLP technology to analyze exome sequencing data. |
WOS关键词 | CTLA-4 BLOCKADE ; PD-1 BLOCKADE ; CANCER ; LANDSCAPE ; BURDEN |
资助项目 | National Natural Science Foundation of China[T2225002] ; National Natural Science Foundation of China[82273855] ; National Natural Science Foundation of China[82204278] ; SIMM-SHUTCM Traditional Chinese Medicine Innovation Joint Research Program[E2G805H] ; Shanghai Municipal Science and Technology Major Project ; National Key Research and Development Program of China[2022YFC3400504] |
WOS研究方向 | Biochemistry & Molecular Biology ; Mathematical & Computational Biology |
语种 | 英语 |
WOS记录号 | WOS:001253138400005 |
出版者 | OXFORD UNIV PRESS |
源URL | [http://119.78.100.183/handle/2S10ELR8/312131] ![]() |
专题 | 新药研究国家重点实验室 |
通讯作者 | Li, Xutong; Zheng, Mingyue |
作者单位 | 1.Lingang Lab, Shanghai 200031, Peoples R China 2.Chinese Acad Sci, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai Inst Mat Med, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China 3.Univ Sci & Technol China, Sch Life Sci, Div Life Sci & Med, Hefei 230026, Peoples R China |
推荐引用方式 GB/T 7714 | Wang, Kun,Shi, Jiangshan,Tong, Xiaochu,et al. TG468: a text graph convolutional network for predicting clinical response to immune checkpoint inhibitor therapy[J]. BRIEFINGS IN BIOINFORMATICS,2024,25(2):15. |
APA | Wang, Kun.,Shi, Jiangshan.,Tong, Xiaochu.,Qu, Ning.,Kong, Xiangtai.,...&Zheng, Mingyue.(2024).TG468: a text graph convolutional network for predicting clinical response to immune checkpoint inhibitor therapy.BRIEFINGS IN BIOINFORMATICS,25(2),15. |
MLA | Wang, Kun,et al."TG468: a text graph convolutional network for predicting clinical response to immune checkpoint inhibitor therapy".BRIEFINGS IN BIOINFORMATICS 25.2(2024):15. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。